IP Library Granted Patent US 8,791,071
Granted Patent B1
US 8,791,071 · App. 14/246,588 · Granted Jul 29, 2014

Cartilage material

Inventor: Theodore I. Malinin (Key Biscayne, FL)
Assignee: Vivex Biomedical, Inc.
A61L27/3612A61L2430/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,791,071
App. No.
14/246,588
Granted
Jul 29, 2014
Kind
B1
Abstract

Cartilage materials such as cartilage fluff and a cartilage composition comprising a particulate material are disclosed. These are suitable for stimulating chondrogenesis and/or producing cartilage regeneration. Also disclosed are processes for their preparation. Methods for regenerating articular cartilage are also disclosed, which involve, for example, placing the cartilage fluff or cartilage composition into a cartilage defect.

Claims (6)

1. A treatment method of regenerating articular cartilage comprising: administering a therapeutically effective amount of a cartilage fluff composition at the site of a cartilage defect, the fluff having a size 1,100 μm to 6,000 μm made of a plurality of intertwined branched strands in the form of a continuous network of cartilage fluff for packing; and packing the cartilage fluff into the site, wherein the fluff is directly packed with or without the use of a vehicle.

2. The treatment method of claim 1 wherein the fluff is directly packed without the use of a vehicle.

3. The treatment method of claim 1 further comprises the step of: using an overlying cover.

4. The treatment method of claim 1 further comprises the step of: administering one or more additional growth promoting factors or additives applied to the cartilage fluff to increase chondrocyte migration and proliferation.

5. The treatment method of claim 4 wherein the growth factors include one or more of: FGF-2, FGF-5, IGF-1, TGF-13, BMP-2, BMP-7, PDGF, VEGF, human allogenic or autologous chondrocytes, human allogenic or autologous bone marrow cells, stem cells, demineralized bone matrix, insulin, insulin-like growth factor-I, transforming growth factor-B, interleukin-1 receptor antagonist, hepatocyte growth factor, platelet-derived growth factor, Indian hedgehog or parathyroid hormone-related peptide.

6. The treatment method of claim 1 wherein the cartilage fluff releases cartilage growth factors that induce or enhance regeneration of articular cartilage.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2022
From: BANKUNITED, N.A.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 061333/0853 →
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2020
From: MALININ, THEODORE I.
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 051875/0714 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2019
From: VIVEX BIOLOGICS GROUP, INC.
To: BANKUNITED, N.A.
Reel/Frame 051260/0064 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOMEDICAL, INC.
To: VIVEX BIOLOGICS, INC.
Reel/Frame 050079/0179 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOLOGICS, INC.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 050079/0225 →
SECURITY INTEREST Recorded Feb 22, 2017
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 041782/0452 →
Continuity (3)
Division 13966676 · Aug 14, 2013
Continuation 13006949 · Jan 14, 2011
Division 11746877 · May 10, 2007